Veeva introduces new epro application for faster access to patient data

Veeva epro simplifies the collection and exchange of patient-reported outcomes in digital clinical trials pleasanton, calif. , oct. 18, 2022 /prnewswire/ -- veeva systems (nyse: veev) today announced the availability of veeva epro, a key advancement in patient-centric digital trials.
VEEV Ratings Summary
VEEV Quant Ranking